The goal of this project is to use MRI and CSF biomarkers to identify in cognitively normal (NL) subjects, the earliest clinically detectable brain changes of Alzheimer's disease (AD). Neuropathology studies show, in mild cognitive impairment (MCI) and some NL individuals, neurofibrillary and plaque pathology that is associated with neuronal and volume losses in the entorhinal cortex (EC) and hippocampus. Our recent in vivo MRI and PET studies of the EC show that volume and metabolism reductions predict the conversion of NL to future MCI. However, in vivo imaged changes lack disease specificity. Our most recent studies and those of our collaborators show that tangle-related abnormal tau proteins, hyper-phosphorylated at threonine 231 (P-tau231), are: 1) elevated in the CSF in MCI; 2) useful in predicting further cognitive decline; and 3) diagnostically specific for AD. Our cross-sectional diagnosis and longitudinal data demonstrate that P-tau231 significantly adds to the MRI hippocampal volume in the diagnosis of MCI. Moreover, we recently published an MRI-based technique that improves detection of longitudinal P-tau231 increases in MCI by controlling for progressive ventricular CSF volume dilution. Our pilot studies also show that amyloid beta 1-40 (Abeta40) levels are elevated in MCI. Overall, these findings suggest that a sensitive and specific recognition of AD in the normal stages of cognition is close at hand. We plan to complete over 5-years a longitudinal MRI and CSF study consisting of a baseline and two 18-month follow-up exams on 80 elderly NL subjects currently active in a longitudinal MRI study of aging and memory. To enrich the sample with individuals at increased risk for progressive cognitive decline, 50 of the subjects will be selected on the basis of subjective memory complaints. Longitudinally studied FTD patients are available to examine specificity. We will use quality controlled and standardized protocols at each observation to collect norm-referenced neuropsychological data; high-resolution MRI; and CSF. Our major hypothesis is that CSF P-tau231 measurement improves the accuracy (specificity) of MRI EC atrophy and CSF Abeta measurements in prediction of the conversion from NL to MCI. All the required imaging and clinical components for this study are active. Ample numbers of subjects are available, and we already completed the proposed three evaluations on 8 eligible NL subjects. There is adequate statistical power for testing the hypotheses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG022374-05
Application #
7410016
Study Section
Clinical Neuroscience and Disease Study Section (CND)
Program Officer
Hsiao, John
Project Start
2004-06-15
Project End
2010-04-30
Budget Start
2008-05-01
Budget End
2010-04-30
Support Year
5
Fiscal Year
2008
Total Cost
$443,819
Indirect Cost
Name
New York University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Katsumata, Yuriko; Nelson, Peter T; Ellingson, Sally R et al. (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25
Kim, H-J; Oh, S-I; de Leon, M et al. (2017) Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state. Eur J Neurol 24:122-129
Ezzati, Ali; Wang, Cuiling; Lipton, Richard B et al. (2017) Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology. J Am Geriatr Soc 65:1836-1841
Grober, Ellen; Wakefield, Dorothy; Ehrlich, Amy R et al. (2017) Identifying memory impairment and early dementia in primary care. Alzheimers Dement (Amst) 6:188-195
Sundermann, Erin E; Katz, Mindy J; Lipton, Richard B (2017) Sex Differences in the Relationship between Depressive Symptoms and Risk of Amnestic Mild Cognitive Impairment. Am J Geriatr Psychiatry 25:13-22
Verghese, Joe; Lipton, Richard; Ayers, Emmeline (2017) Spatial navigation and risk of cognitive impairment: A prospective cohort study. Alzheimers Dement 13:985-992
Seng, Elizabeth K; Buse, Dawn C; Klepper, Jaclyn E et al. (2017) Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache Center. Headache 57:593-604
Kline, R; Wong, E; Haile, M et al. (2016) Peri-Operative Inflammatory Cytokines in Plasma of the Elderly Correlate in Prospective Study with Postoperative Changes in Cognitive Test Scores. Int J Anesthesiol Res 4:313-321
Lauritsen, Clinton; Mazuera, Santiago; Lipton, Richard B et al. (2016) Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain 17:106
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717

Showing the most recent 10 out of 124 publications